American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

Vaccination Coverage in Adults Remains Low, Says CDC

Slight Increases Reported in Tdap, Herpes Zoster, HPV Vaccine Coverage

By Lisa Curran

Adult vaccination coverage increased slightly overall in 2010 compared with 2009 but remains low and shows little progress in meeting Healthy People 2020 targets. That's according to CDC-analyzed data from the 2010 National Health Interview Survey.
Stock photo-man getting flu shot
The CDC analysis, which was published Feb. 3 in Morbidity and Mortality Weekly Report, reported increases in coverage for tetanus, diphtheria and acellular pertussis vaccine in people ages 19-64 (a 1.6 percent increase to 8.2 percent); herpes zoster vaccine among people 60 and older (a 4.4 percent increase to 14.4 percent); and one or more doses of human papillomavirus (HPV) vaccine in women ages 19-26 (a 3.6 percentage point increase to 20.7 percent).

Coverage rates for pneumococcal and hepatitis B vaccines remained virtually unchanged, while hepatitis A vaccine coverage ticked up only slightly among people ages 19-49. Influenza vaccination coverage estimates for the 2010-11 season were published separately.

Jamie Loehr, M.D., of Ithaca, N.Y., the AAFP's liaison to the CDC's Advisory Committee on Immunization Practices (ACIP), attributes the low coverage rates to a culture in which adults think they don't need vaccines.

story highlights

  • Adult vaccination rates remain below Healthy People 2020 goals.
  • Coverage rates for tetanus, diphtheria and acellular pertussis; herpes zoster; and human papillomavirus vaccines increased slightly from 2009 to 2010.
  • Coverage rates for pneumococcal, hepatitis A and hepatitis B vaccines remained largely unchanged during that period.
"Most adults are not in high-risk groups, so the only vaccine they think they need is a tetanus shot every 10 years," he said.

Vaccine cost also could be a contributing factor to the low coverage, Loehr told AAFP News Now.

According to the Patient Protection and Affordable Care Act, public insurers and new private health plans (i.e., those established on or after Sept. 23, 2010) are required to cover all ACIP-approved vaccines without cost-sharing. Insurance plans established before that date received grandfather status and are not required to cover such recommended preventive services unless they make significant plan changes that reduce benefits or increase costs to consumers.

Still, cost is only part of the adult vaccination picture, as evidenced by the fact that some of the more expensive vaccines, including the herpes zoster and HPV vaccines, actually saw modest increases in 2010.

Overall, adult vaccination coverage is much lower than children's vaccination coverage, which is about 90 percent for most longstanding recommended vaccines, according to a CDC report published last year.

That's likely because almost all children have a person they identify as their doctor -- the person they see for checkups -- who ensures they are vaccinated appropriately, said Loehr.

"Adult care is more fragmented," he noted. "Many adults are healthy and don't have a doctor."
More From AAFP
American Family Physician: AFP by Topic: "Immunizations (excluding Influenza)"
(Some content may be available to members/paid subscribers only)


Share this on AAFP Connection

Search AAFP News Now

 

Health of the Public

AAFP, USPSTF Recommend Against Routine PSA Screening

Inadequate, Disordered Sleep Increases Diabetes Risk

Text Messaging Could Hike Vaccination Rates

Fluoroquinolones Tied to Greater Retinal Detachment Risk

Sanofi Announces DTaP Vaccine Shortage

AHRQ Resources Provide Ready Access to Research Data

Community-onset C. difficile Infections on the Rise

New FamilyDoctor.org Content Helps With Caring for Elderly

U.S. Measles Cases in 2011 Highest in 15 Years

FDA Warns of More Finasteride Side Effects

'Take-Back' Initiative Focuses on Destroying Unwanted Drugs

Bariatric Surgery May Help Combat Type 2 Diabetes

Certain Skin Products Tied to Mercury Poisoning

FDA Clarifies Citalopram Usage, Dosing Warnings

Veterans With PTSD at Heightened Risk for Opioid Abuse

ACP Releases Guideline on Type 2 Diabetes Management

Office Champions Seeking Applicants for Second Wave

Surgeon General Releases Report on Teen Smoking

USPSTF Issues Final Cervical Cancer Screening Recommendations

FDA Approves First Quadrivalent Influenza Vaccine

Survey: Physicians May Have Trouble Interpreting Cancer Statistics

AIM-HI Nutrition Questionnaire Can Open Dialogue

Statin, HIV/Hepatitis C Drug Interactions May Pose Risks

Statin Therapy Effective in Both Genders, Study Suggests

AAFP, CDC Announce Immunization Schedule Change

Family Physicians on Front Lines of Caring for Vets

ACIP Votes to Expand Tdap Recommendation

Recalled Oral Contraceptives Pose Pregnancy Risk

Studies Shed Light on Vaccine Side Effect Risks

Dosing Problems Prompt Recall of Infants' Tylenol Products

TB 'Superbug' Not Stateside Threat, Says FP

Adult Vaccination Coverage Remains Low, Says CDC

FDA Warns of Health Risk Tied to PPI Use

Study: PPI Does Not Routinely Improve Asthma Control

Recalled Oral Contraceptives Pose Pregnancy Risk

CDC to Fund 2D Vaccine Barcoding Pilot

2012 Immunization Schedules Reflect Multiple Changes

Study: Cognitive Decline Detected in Middle-aged Adults

CDC Toolkit Can Help Clinicians Fight Norovirus Infection

Patient-Centered Care Linked to Lower Mortality

Study: Inappropriate Cancer Screenings Continue

Novartis Manufacturing Plant Closes After Drug Mix-ups

FDA Announces Classwide REMS for TIRF Medications